Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603Yoshikazu Ohta, Haruhiko Makino, Ryoichi Tsukuda et al.|Immunopharmacology|1996Cited by 14
Reduction of disease causative T-cells in experimental autoimmune disease models by a new antirheumatic drug, TAK-603Yoshikazu Ohta, Haruhiko Makino, Shigeru Fukuda|Immunopharmacology|1997Cited by 1